Novel anti-nectin-4 antibodies and antibody-drug conjugates
US-2026062481-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Olive Daniel patents
Olive Daniel is listed as an inventor on 68 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Olive Daniel |
| Total patents | 68 |
| First publication | May 28, 2015 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2026021194-A1 · Jan 22, 2026 · US
Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload
US-12419964-B2 · Sep 23, 2025 · US
Antibodies having specificity for nectin-4 and uses thereof
US-12398206-B2 · Aug 26, 2025 · US
Novel formats of anti-CD28/sPD-1 fusion constructs
US-2025197499-A1 · Jun 19, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Butyrophilin (btn) 3a activating antibodies for use in methods for treating infectious disorders
US-2025129165-A1 · Apr 24, 2025 · US
Antibodies having specificity for BTN2 and uses thereof
US-12258400-B2 · Mar 25, 2025 · US
BTN3A binding proteins and uses thereof
US-12247075-B2 · Mar 11, 2025 · US
Anti-nectin-4-antibodies and uses thereof
US-2025018053-A1 · Jan 16, 2025 · US
Recent patents
Latest publications not already listed above.
Anti-nectin-4-antibodies and uses thereof
US-12049500-B2 · Jul 30, 2024 · US
Anti-nectin-4 antibody amanitin conjugates
US-2024181075-A1 · Jun 6, 2024 · US
Anti-nectin-4-antibody exatecan conjugates
US-2024173424-A1 · May 30, 2024 · US
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
US-11987631-B2 · May 21, 2024 · US
Antibodies having specificity for btn2 and uses thereof
US-2024117041-A1 · Apr 11, 2024 · US
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
US-11945871-B2 · Apr 2, 2024 · US
Anti-CD277 antibodies
US-11904004-B2 · Feb 20, 2024 · US
Anti-nectin-4-antibodies and uses thereof
US-2024034791-A1 · Feb 1, 2024 · US
Anti-cd25 antibodies
US-2024002521-A1 · Jan 4, 2024 · US
Anti-cd25 antibodies
US-2024002522-A1 · Jan 4, 2024 · US
Anti-btn3a antibodies and their use in treating cancer or infectious disorders
US-2023322932-A1 · Oct 12, 2023 · US
Anti-cd277 antibodies and uses thereof
US-2023285527-A1 · Sep 14, 2023 · US
Anti-btn3a antibodies and their use in treating cancer or infectious disorders
US-2023272080-A1 · Aug 31, 2023 · US
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas
US-2023181753-A1 · Jun 15, 2023 · US
Antibodies having specificity for btla and uses thereof
US-2023183346-A1 · Jun 15, 2023 · US
Antibodies having specificity for nectin-4 and uses thereof
US-2023183337-A1 · Jun 15, 2023 · US
Antibodies having specificity for BTN2 and uses thereof
US-11572409-B2 · Feb 7, 2023 · US
Novel anti-cd25 antibodies
US-2022251232-A1 · Aug 11, 2022 · US
Antibodies having specificity for btn2 and uses thereof
US-2022162305-A1 · May 26, 2022 · US
Anti-btn3a antibodies and their use in treating cancer or infectious disorders
US-2022112289-A1 · Apr 14, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Aix Marseille | 64 |
| Inst Nat Sante Rech Med | 56 |
| Inst Jean Paoli & Irene Calmettes | 55 |
| Centre Nat Rech Scient | 30 |
| Centre Leon Berard | 14 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 50 |
| A61K2039/505 | 46 |
| C07K16/2818 | 38 |
| C07K2317/92 | 37 |
| C07K2317/565 | 33 |